Journal article 572 views
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
Steve Bain 
,
Thinzar Min
,
Thinzar Min
The Lancet, Volume: 402, Issue: 10401
Swansea University Authors:
Steve Bain , Thinzar Min
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/s0140-6736(23)01182-0
Abstract
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
| Published in: | The Lancet |
|---|---|
| ISSN: | 0140-6736 |
| Published: |
Elsevier BV
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa63790 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
10401 |